Diabetes Technology Meeting

2020 Meeting Agenda (All Times Pacific)Register NowLog In

Wednesday, November 11, 2020 Pre-Meeting Sessions

Conversation With the Professor

8:30

Chat With:

Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA

9:00

Chat With:

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

9:30

Chat With:

Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Neuss, Germany

Product Theater

10:00

Ascensia Presents: CGM and Telehealth, Before, During, and After COVID-19

Francine R. Kauffman, MD
Chief Medical Officer, Senseonics, Inc., Germantown, Maryland, USA

11:00

Lifescan Presents: HCP Perceptions of the Clinical Value and Utility of Current Blood Glucose Meters (CONVINCE Study)

Mike Grady, MSc, PhD
Director WW Clinical Affairs LifeScan, Inverness, United Kingdom

11:30

Abbott Diabetes Care Presents: Introducing the FreeStyle Libre 2 System

Eden Miller, DO
High Lakes Health Care, Bend, Oregon, USA

12:00

BD Presents: When Insulin Injection Depth is Too Deep: What Happens and How to Prevent It

Timothy S. Bailey, MD, FACE, CPI
President & CEO AMCR Institute, Escondido, California, USA
Clinical Associate Professor, UCSD School of Medicine, La Jolla, California, USA

Brian K Pflug, PharmD
Global Medical Director US/Canada
BD Diabetes Care Medical Affairs, Franklin Lakes, New Jersey, USA

12:30

Dexcom Presents: The Role of Continuous Data in Remote Patient Monitoring

Egils Bogdanovics, MD
Charlotte Hungerford Hospital, Torrington, Connecticut, USA

Adam Wolfberg, MD, MPH
Chief Medical Officer, Current Health, New York City, New York, USA

1:00

Glytec Presents: Insulin Management Optimized. Uniting Your Team on Patient Safety

Andy O’Dell
Regional Vice President
Glytec, Atlanta, Georgia, USA

Jordan Messler, MD, SFHM, FACP
Executive Director, Clinical Practice
Glytec, Largo, Florida, USA

Thursday, November 12, 2020

Workshop 1: Novel Software

Panel 1: Artificial Intelligence

8:00

Moderators:

Wayne Bequette, PhD
Rensselaer Polytechnic Institute, Troy, New York, USA

Piotr Ladyzynski, PhD
Nalecz Institute of Biocybernetics and Biomedical Engineering of the Polish Academy of Sciences, Warsaw, Poland

8:05

CGM-AI: From Pattern Recognition to Automatic Control

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

8:20

Clinical Uses of Artificial Intelligence

Moshe Phillip, MD
National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel

8:35

Use of Artificial Intelligence in the Design of Decision Support Systems

Peter Jacobs, PhD
Oregon Health and Science University, Portland, Oregon, USA

8:50

An Artificial Intelligence Augmented Mobile APP

Mercedes Rigla, MD, PhD
Parc Taulí Sabadell University Hospital, Barcelona, Spain

9:05

Q&A / Panel Discussion

9:30

Break

Panel 2: Digital Health and Telemedicine

9:55

Moderators:

David Ahn, MD
Mary & Dick Allen Diabetes Center at Hoag, Newport Beach, California, USA

Jennifer Raymond, MD, MCR
University of Southern California, Los Angeles, California, USA

10:00

Diabetes Telehealth: We’re Doing It… But How Do We Make It Better & Easier?

Aaron Neinstein, MD
UCSF, San Francisco, California, USA

10:15

Integrated Personalized Diabetes Management (IPDM) In an Open Ecosystem – Paving the Way for Advanced Outcomes in Diabetes Therapy

Rolf Hinzmann, MD, PhD
Roche Diagnostics, Manheim, Germany

10:30

Digital Health Tools to Improve Adherence to Blood Glucose Monitoring

Elizabeth Holt, MD, FACE
Lifescan, Wayne, Pennsylvania, USA

10:45

The Benefits of a Multi-Sensor Platform for Diabetes

Mark Clements, MD, PhD
Glooko, Mountain View, California, USA

11:00

Telemedicine to Support Personalized Care

Ronald Dixon, MD
Remedy, Austin, Texas, USA

11:15

Q&A

11:40

Lunch

Workshop 2: Glucose Monitoring

Panel 1: Noninvasive

12:40

Moderators:

Gerard Coté, PhD
Texas A & M University, College Station, Texas, USA

Brian Frier, BSc (Hons), MD, FRCP(Edin), FRCP(Glas)
University of Edinburgh, Edinburgh, Scotland

12:45

Fundamental Issues That Limit Successful Non-Invasive Glucose Measurements

Mark Arnold, PhD
University of Iowa, Iowa City, Iowa, USA

13:00

Optical Methods for Non-Invasive Glucose Sensing – Breakthrough or Broken Promises Again?

Michael Heise, PhD
South-Westphalia University of Applied Science, Iserlohn, Germany

13:15

Detection of Hypoglycemia with Non-Invasive Sensors in Subjects with Impaired Awareness of Hypoglycemia.

Kåre Birkeland, MD
Aker University Hospital, Oslo, Norway

13:30

Tear Glucose: Fact or Fiction?

Christopher Wilson, PhD
Listerdale Lifescience BV, Nijmegen, Netherlands

13:45

Skin-Interfaced Wearable Sweat Biosensors

Wei Gao, PhD
California Institute of Technology, Pasadena, California, USA

14:00

Q&A

14:20

Break

Panel 2: Novel Technologies in CGMs

14:45

Moderators:

Jennifer Sherr, MD, PhD
Yale University, New Haven, Connecticut, USA

Hubert Vesper, PhD
Centers for Disease Control and Prevention, Atlanta, Georgia, USA

14:50

CGM Usage for the Management and Reversal of Type 2 Diabetes

Faz Chowdhury, PhD
CEO, Nemaura Medical, Loughborough, UK

15:05

Senseonics Eversense CGM System

Francine Kaufman, MD
Senseonics, Germantown, Maryland, USA

Andreas Stuhr, MD, MBA
Ascensia Diabetes Care, Parsippany, New Jersey, USA

15:20

Waveform Technologies

Mihailo Rebec, PhD
Waveform Technologies, Wilsonville, Oregon, USA

15:35

Performance of a Next Generation iCGM System

Marc Taub, PhD
Abbott Diabetes Care, Alameda, California, USA

15:50

Dexcom Technologies

Peter Simpson, MS
DexCom, Inc., San Diego, California, USA

16:05

Integrated CGM Systems – Enabling Technologies for Usability & Comfort

Akhil Srinivasan, PhD
Medtronic Diabetes, Washington DC, USA

16:20

Q&A / Panel Discussion

16:45

End of Workshop

Friday, November 13, 2020

8:00

Introduction

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA

8:05

Regulatory Trends at the FDA in Diabetes Devices

Timothy Stenzel, MD, PhD
Director, Office of In Vitro Diagnostics and Radiological Health at the FDA, Silver Spring, Maryland, USA

Session 1: What Are the Best Metrics for Expressing Glycemia in CGM?

8:30

Moderators:

Guillermo Arreaza-Rubin, MD
NIDDK/NIH, Bethesda, Maryland, USA

Jessica Castle, MD
Oregon Health Sciences University, Portland, Oregon, USA

8:30

Time-In-Range or HbA1c: Why Not Both?

Lutz Heinemann, PhD
Science Consulting in Diabetes GmbH, Neuss, Germany

8:40

Metrics for Evaluation of Quality of Glycemic Control

David Rodbard, MD
Biomedical Informatics Consultants LLC, Potomac, Maryland, USA

8:50

Essential Metrics: The Principal Components of a CGM Daily Profile

Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA

9:00

Interconnected Relationships of Metrics in the AGP

Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota, USA

9:10

Q&A / Panel Discussion

Session 2: What role does BGM have in the future?

9:40

Moderators:

Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer, American Diabetes Association, Arlington, Virginia, USA

John Pickup, MA, BM, DPhil, DSc, FRCPath
King's College London, London, United Kingdom

Presentation of Diabetes Technology Leadership Award

9:45

BGM in the 21st Century: A Perspective

Robert Schumm, MBA
President, Ascensia Diabetes Care, Basel, Switzerland

9:55

Applications of BGM

Richard Bergenstal, MD
International Diabetes Center, Minneapolis, Minnesota, USA

10:05

Is BGM Dead?

Steven Edelman, MD
Veterans Affairs Medical Center, UC San Diego, La Jolla, California, USA

10:15

Blood Glucose Assessment in a Digitalized Sensor Ecosystem Environment – Future Perspectives

Andreas Pfützner, MD, PhD
Pfützner Science and Health Institute, Mainz, Germany

10:25

Trends in Capillary BGM

Irl Hirsch, MD
University of Washington School of Medicine, Seattle, Washington, USA

10:35

Q&A / Panel Discussions

11:00

Break

Session 3: What are recent developments in regulatory science for diabetes devices?

11:25

Moderators:

Alberto Gutierrez, PhD
NDA Partners, LLC, Rochelle, Virginia, USA

Yarmela Pavlovic, JD
Manatt Health, San Francisco, California, USA

11:35

Insulin Dosing Software

Naomi Schwartz, MS
FDA, Silver Spring, Maryland, USA

11:45

Automated Insulin Dosing Systems

Yiduo Wu, PhD
FDA, Silver Spring, Maryland, USA

11:55

Cybersecurity

Suzanne Schwartz, MD, MBA
FDA, Silver Spring, Maryland, USA

12:05

Real World Evidence

Ken Quinto, MD, MPH
FDA, Silver Spring, Maryland, USA

12:15

Q&A / Panel Discussion

12:40

Lunch

Session 4: What is the role of pharma in Digital Health?

13:35

Moderators:

Juan Espinoza, MD, FAAP
University of Southern California, Los Angeles, California, USA

Matthew Taylor, CFA
MedTech Supplies & Devices Analyst, UBS-ARC, New York, New York, USA

13:40

Diabetes Is a Wicked Problem

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

13:50

Unleashing the Potential of Connected Insulin Pens

Howard Wolpert, MD
Lilly Cambridge Innovation Center, Cambridge, Massachusetts, USA

14:00

New Components for the Virtual Digital Diabetes Clinic That Will Improve Outcomes and Efficiency

Anders Toft, MD, PhD, eMBA
Novo Nordisk, Copenhagen, Denmark

14:10

Levels of Complexity and Reward from Digital Health

Christopher Boulton, BSc
Sanofi, Bridgewater, New Jersey, USA

14:20

Digital Health Change How Patients Are Using Drugs: A New Parameter in Drug Development

Sam Collaudin, PhD, jMBA
Quarterly R&D Diabetes News Report, Marburg, Germany

14:30

Q&A / Panel Discussion

Session 5: Artificial Pancreas (What do patients like and dislike about their automated insulin delivery systems?)

15:05

Moderators:

Bruce Buckingham, MD
Stanford University, Palo Alto, California, USA

Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia, USA

15:10

Patient Panel (Users of Four Automated Insulin Delivery Systems)

15:30

Break

Session 6: Can we build a fully automated AP without pre-meal announcements?

15:50

Moderators:

Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Laurel Messer, PhD, RN, CDCES
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA

Presentation of Artificial Pancreas Award

15:55

Anticipating Glycemic Disturbances to Control Unannounced Meals and Exercise

Marc Breton, PhD
University of Virginia, Charlottesville, Virginia, USA

16:07

Fully Automated AP Without Pre-Meal Announcements

Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA

16:19

Eliminating Meal Announcements

Roman Hovorka, PhD, FMedSci
University of Cambridge, Cambridge, UK

16:31

Multivariable Control for the Artificial Pancreas

Frank Doyle, PhD, CPGS
Dean, Harvard John A. Paulson School of Engineering & Applied Sciences, Cambridge, Massachusetts, USA

16:43

Q&A / Panel Discussion

17:00

End of Session

Saturday, November 14, 2020

Session 7: What is the role of ultra short acting and ultra long acting analog insulins?

7:50

Moderators

Gerold Grodsky, PhD
UCSF, San Francisco, California, USA

Tim Heise, MD
Profil, Neuss, Germany

Presentation of Student Research Awards

8:05

The Clinical Need for Ultra Short Acting and Ultra Long Acting Analog Insulins

Anne Peters, MD, FACP, CDE
University of Southern California, Los Angeles, California, USA

8:15

Ultrarapid Insulin Aspart Injection (Fiasp Insulin). What Will Be Its Role?

Athena Philis-Tsimikas, MD
Scripps Whittier Institute for Diabetes, UC San Diego, San Diego, California, USA

8:25

Ultrarapid Lispro (Lyujev) Insulin. What Will Be Its Role?

Leslie Klaff, MD, PhD
Rainier Clinical Research, Renton, Washington, USA

8:35

Hepatic Directed Insulin

Bruce Bode, MD
Atlanta Diabetes Associates, Atlanta, Georgia, USA

8:45

Inhaled Insulin for Pulmonary Delivery

Eda Cengiz, MD, FAAP, MHS
Yale University School of Medicine, New Haven, Connecticut, USA

8:55

Weekly Basal Insulin Icodec…The Way of the Future!

Julio Rosenstock, MD
Dallas Diabetes and Endocrine Center, Dallas, Texas, USA

9:05

Q&A / Panel Discussion

9:20

End of Session

Session 8: How should the performance of CGM systems be evaluated?

9:20

Moderators:

Craig Kollman, PhD
Jaeb Center for Health Research, Tampa, Florida, USA

Carlos Mendez, MD, FACP
Medical College of Wisconsin, Milwaukee, Wisconsin, USA

9:25

CGM Accuracy – A Clinical Perspective

Tim Bailey, MD, FACE, FACP, CPI
AMCR Institute, Escondido, California, USA

9:40

A Review of the Proposed Performance Metrics for Continuous Interstitial Glucose Monitoring, Under Development by the Clinical and Laboratory Standards Institute (CLSI)

David Horwitz, MD, PhD
DLH Biomedical Consulting LLC, Las Vegas, Nevada, USA

9:55

IFCC CGM-WG: Improving Standardization of Continuous Glucose Monitoring

Guido Freckmann, MD
Institute for Diabetes Technology GmbH, Ulm, Germany

10:10

The DTS Guideline for Continuous Glucose Monitors and Automated Insulin Dosing Systems in the Hospital

Rodolfo Galindo, MD, FACE
Emory University School of Medicine, Atlanta, Georgia, USA

10:25

How the Security Performance of CGMs (And Other Connected Diabetes Devices) Should Be Evaluated

David Kleidermacher, BS
Google, Mountain View, California, USA

10:40

Q&A / Panel Discussion

10:55

Break

Session 9: Is digital health discriminatory?

11:20

Moderators:

Andrew Bremer, MD, PhD
NIDDK/National Institutes of Health, Bethesda, Maryland, USA

Sarah Kim, MD
UCSF, San Francisco, California, USA

11:20

Technology Is Not the Silver Bullet

Fazlyn Petersen, PhD
University of Western Cape, Cape Town, South Africa 

11:30

Digital Health in the Military

Karl Friedl, PhD, COL
USAMRMC/Telemedicine and Advanced Tech Research Center, Fort Detrick, Maryland, USA

11:40

A Level Playing Field

Celeste Campos-Castillo, PhD
University of Wisconsin Milwaukee, Milwaukee, Wisconsin, USA

11:50

Developing Technology for Digital Health

Keesha Perkins-Crosby, MS
Tri-Guard Risk Solutions, LTD, Arlington, Virginia, USA

12:00

Technology Capacity and Literacy for Urban Poor

Elizabeth Burner, MD, MPH
University of Southern California, Los Angeles, California, USA

12:10

Q&A / Panel Discussion

12:25

Lunch

Session 10: Does real time diabetes monitoring require more metrics than glucose?

13:20

Moderators:

Avner Gal, MBA., MSCEE, MSc
Iridium Consultancy and Technologies, Ltd., Herzliya, Israel

Barry Ginsberg, MD, PhD
Diabetes Technology Consultants, Wyckoff, New Jersey, USA

13:25

Smart Insulin Pens

Hope Warshaw, MMSc, RD, CDCES, BC-ADM
Hope Warshaw Associates, Alexandria, Virginia, USA

13:35

Use of Exercise Monitors to Provide Additional Information for Monitoring Diabetes

Dessi Zaharieva, PhD
Stanford University, Palo Alto, California, USA

13:45

Use of Activity Data from Wearable Trackers in T2D Research

Christian Cerrada, PhD
Evidation Health, Inc., San Mateo, California, USA

13:55

Multi-Sensor Platforms

Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA

14:05

Sensors to Prevent, Monitor, and Treat Foot Ulcers

Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas, USA

14:15

Q&A / Panel Discussion

14:30

Break

Session 11: Can glucose monitoring predict the future?

14:50

Moderators:

Thanh Hoang, DO
Walter Reed National Military Medical Center, Bethesda, Maryland, USA

Umesh Masharani, MD
UCSF, San Francisco, California, USA

14:55

CGM-Informed Prediction Tools

Chiara Fabris, PhD
University of Virginia, Charlottesville, Virginia, USA

15:05

Classification of Hypoglycemia – The Hypo-RESOLVE Project

Bastiaan de Galan, MD, PhD
Maastricht University Medical Centre, Maastricht, Netherlands
Radboud University Medical Centre, Nijmegen, Netherlands

15:15

Low Sensor Glucose and Hypoglycemia – Are They the Same? The HypoMETRICS Project

Pratik Choudhary, MBBD, MRCP, MD
University of Leicester, Leicester, UK

15:25

Yes, Glucose Monitoring Can Predict the Future

Dan Goldner, PhD
One Drop, New York, New York, USA

15:35

Simplifying Diabetes Management Through Glucose Prediction

Pratik Agrawal, MS
Medtronic Diabetes, Northridge, California, USA

15:45

Software to Achieve Target Glycemia

Jordan Messler, MD, SFHM, FACP
Glytec, Largo, Florida, USA

15:55

Q&A / Panel Discussion

16:10

End of Session

Live Demonstration

16:10

Moderators:

Rodolfo Galindo, MD, FACE
Emory University School of Medicine, Atlanta, Georgia, USA

Eun-Jung Rhee, MD, PhD
Kangbuk Samsung Hospital, Seoul, South Korea

16:15

Smart Socks for Diabetic Foot Ulcers

Bijan Najafi, PhD
Baylor College of Medicine, Houston, Texas, USA

16:40

Closing Statements

David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA

16:45

End

Thursday, November 19, 2020

Virtual Poster Session

Session A

Moderators:

Shashank Joshi, MD, DM, FICP, FACP(USA), FACE(USA), FRCP(Lon,Glsg & Edin)
Lilavati Hospital and Research Centre, Mumbai, India

Julia Mader, MD, PhD
Medical University of Graz, Graz, Austria

8:30

Impact of the MiniMed™ AHCL system on post-prandial glucose after a missed meal bolus in adolescents and adults with type 1 diabetes (T1D)

Jennifer Sherr, MD, PhD et al.

8:34

Individualized Linear Models for Glucose Prediction: Parametric vs. Non-Parametric Identification

Simone Faccioli, MSc et al.

8:38

Classification of Daily Continuous Glucose Monitoring (CGM) Profiles in Type 1 Diabetes Using Layered Clustering and Clinical Metrics

Mahdi Shafiei, PhD et al.

8:42

Pulsatile Insulin Treatment as  a Treatment Option for Patients with Type 2 Diabetes and Stage III Kidney Failure – Results from a Pilot Study

Andreas Pfützner, MD, PhD et al.

8:46

The Burden of Hypoglycemia during Real-World Conditions

Felix Aberer, MD et al.

8:50

A New Model for Mealtime Insulin Dosing in Type 1 Diabetes: Retrospective Validation on CTR3 Dataset

Giulia Noaro, MSc et al.

8:54

Q & A / Panel Discussion

Session B

Moderators:

John Nolan, MD, FRCPI, FRCP(Ed), FTCD (hon)
Trinity College Dublin, Dublin, Ireland

Gerry Rayman, MD, FRCP
The Ipswich Diabetes Centre Ipswich Hospital, Ipswich, UK

9:15

Predicting Blood Glucose Levels Using CNN-LSTM Neural Networks

Mehrad Jaloli, MSc et al.

9:19

Determining the Optimal Duration of a Clinical Trial Having Time-in-ranges as Final Endpoints

Nunzio Camerlingo, MSc et al.

9:23

Highly Miniaturized, Low Power CMOS ASIC for Long-Term, Needle-Implantable CGMs

Raja Hari Gudlavalleti, MS et al.

9:27

Expected Variability in Estimated Insulin Secretion from C-peptide using Van Cauter Kinetic Parameters

Jennifer J. Ormsbee, MSc et al.

9:31

Preliminary Assessment of a Mass Manufacturable Point-of-Care Insulin Sensor

Madison Strong, NONE et al.

9:35

Intravenous Automated Blood Glucose Control with No Meal Announcement. A Prospective Time-in-Range In Silico Study

Adrian Tarniceriu, PhD et al.

9:39

Q & A / Panel Discussion

Session C

Moderators:

Lori Laffel, MD, MPH
Joslin Diabetes Center Harvard Medical School, Boston, Massachusetts, USA

Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, Maryland, USA

10:00

Variations in Time in Range Assessed by CGM in the Early COVID-19 Pandemic

Joost van der Linden, PhD et al.

10:04

A Massive Open Online Course for Type 2 Diabetes Self-Management: Adapting Education in the COVID-19 Era

Scott Mackenzie, BMSc (Hons) MBChB et al.

10:08

Use of the Sencell Osmotic Pressure-Based Glucose Sensor in a Standard Needle Sensor Environment

Andreas Pfützner, MD, PhD et al.

10:12

Insulin Cost-Savings Comparison: 7-Day Extended Wear Infusion Set with Medtronic Pump vs. 2-3 Day Wear Infusion Set with Non-Medtronic Pump

Sarnath Chattaraj, PhD et al.

10:16

Role of Site Selection & Cannula Length in Insulin Infusion Set Performance

Gina Zhang, PhD et al.

10:20

Insulin, Not the Preservative m-Cresol, Instigates Loss of Infusion Site Patency Over Extended Durations of CSII in Diabetic Swine

Monica Swinney, PhD et al.

10:24

Q & A / Panel Discussion

Session D

Moderators:

Sanjoy Dutta, PhD
Juvenile Diabetes Research Foundation, New York, New York. USA

Boris Mankovsky, MD, PhD
Institute of Endocrinology, Kiev, Ukraine

10:45

Persistent Hyperglycemia in Extremely Low Birth Weight Premature Infants

Jennifer Knopp, PhD et al.

10:49

Significant Reduction in Time-Below-Range (Hypoglycemia) in People with Type 1 Diabetes using an Advanced Hybrid Closed Loop System

Lars Mueller, PhD et al.

10:53

The Effect of a Digital Therapeutic Platform on Glycemic Control in Adults above Age 65 with Type 2 Diabetes

Yifat Hershcovitz, PhD et al.

10:57

Differences in Perceived Quality of Sleep and Satisfaction with Insulin Delivery Device in People with Diabetes

Harsimran Singh, PhD et al.
Oral Presentation by Steph Habif, EdD, MS

11:01

Smart Insulin Pens Allow Correction Doses Between Meals as Needed Without Compromising Time Below Range

Madison Smith, PhD, RN, CDCES et al.

11:05

The Extended Wear Infusion Set- A Design for Plastic Waste Reduction

Hsi Fusselman, MS et al.

11:09

Q & A / Panel Discussion

Session E

Moderators:

Amisha Wallia, MD, MS
Northwestern Unviersity, Chicago, Illinois, USA

Jenise Wong, MD, PhD
UCSF, San Francisco, California, USA

11:30

Diminished Weekday/Weekend Differences in Glycemic Control in the COVID-19 Pandemic

Robert Dowd, BS et al.

11:34

The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia

Sahar Alharthi, MBBS et al.

11:38

Glycemic Outcomes with Adjustable Settings in the Advanced Hybrid Closed-loop (AHCL) System-Pivotal Trial

Anirban Roy, PhD et al.

11:42

Deteriorating Glucose Control in Patients With Diabetes (PWD) after Disengagement From A Mobile Health (mHealth) App

Sarine Babikian, PhD et al.
Oral Presentation by Mark Clements, MD, PhD

11:46

Simulation Platform Development for Diabetes and Technology Self-Management

Eileen Faulds, PhD, MS, RN et al.

11:50

Early Insights from a Digitally Enhanced Diabetes Self-Management Education and Support Program

Folasade Wilson-Anumudu, MPH et al.

11:54

Q & A / Panel Discussion

Session F

Moderators:

Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA

Louis Philipson, MD, PhD
University of Chicago, Chicago, Illinois, USA

12:15

Regional COVID-19 Disease Burden and Individual Changes in Glycemic Control

Joost van der Linden, PhD et al.

12:19

Performance of a Factory-Calibrated Continuous Glucose Monitoring (CGM) System with a Retuned Algorithm

Xiaohe Zhang, MS et al.
Oral Presentation by Rebecca Harvey Towers, PhD

12:23

Closed-Loop Insulin Delivery in Adults with Highly Unstable Type 1 Diabetes Can Outperform Suspend-Before-Low Insulin Pump Technology, a 16-Week Randomized Crossover Trial

Pierre Yves Benhamou, MD et al.

12:27

Cost-utility of an online education platform and diabetes personal health record: analysis over ten years

Scott Cunningham, PhD et al.

12:31

Web-based Simulation Tool for Self-Management Support in Type 1 Diabetes

Patricio Colmegna, PhD et al.

12:35

Predicting Success with a Diabetes mHealth Application from Early Usage Data

Maya Mudambi, MCIT, BA et al.

12:39

Q & A / Panel Discussion